Clinical Outsourcing’s AI Moment: From Manual Comparison to Strategic Oversight
By Stefan Zoričić, MSc, CEO, MedFriend Ltd Today’s closing panel discussion at PCMG26 in Berlin, titled “AI[…]
China’s Acceleration in Clinical Development: Regulation Built the Engine, COVID Pressed the Accelerator
By Stefan Zoricic, MScFounder & CEO, MedFriend Ltd At PCMG, one of the most thought-provoking discussions focused[…]
MedFriend Attends PCMG to Discuss the Future of Clinical Development and CRO Procurement
MedFriend Ltd is pleased to be attending PCMG, bringing together leaders from across clinical operations, outsourcing, procurement,[…]
CRO Selection and Clinical Outsourcing Advisory: Reducing Risk Before Trials Begin
The transition from strategy to clinical execution is one of the most critical and high-risk phases in[…]
Looking Ahead to 2026
As we look ahead to 2026, MedFriend enters the year with clarity of purpose and momentum across[…]
Protecting Biotech Cash Runway Through Smarter CRO Selection
For biotech companies, clinical trials are not just a scientific milestone. They are the single largest driver[…]